735 related articles for article (PubMed ID: 8814247)
1. In interleukin-4-deficient mice, alum not only generates T helper 1 responses equivalent to freund's complete adjuvant, but continues to induce T helper 2 cytokine production.
Brewer JM; Conacher M; Satoskar A; Bluethmann H; Alexander J
Eur J Immunol; 1996 Sep; 26(9):2062-6. PubMed ID: 8814247
[TBL] [Abstract][Full Text] [Related]
2. Neither interleukin-6 nor signalling via tumour necrosis factor receptor-1 contribute to the adjuvant activity of Alum and Freund's adjuvant.
Brewer JM; Conacher M; Gaffney M; Douglas M; Bluethmann H; Alexander J
Immunology; 1998 Jan; 93(1):41-8. PubMed ID: 9536117
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-10-treated dendritic cells do not inhibit Th2 immune responses in ovalbumin/alum-sensitized mice.
Bellinghausen I; Sudowe S; König B; Reske-Kunz AB; Knop J; Saloga J
Int Arch Allergy Immunol; 2006; 141(1):61-9. PubMed ID: 16804328
[TBL] [Abstract][Full Text] [Related]
4. OVA-bound nanoparticles induce OVA-specific IgG1, IgG2a, and IgG2b responses with low IgE synthesis.
Yanase N; Toyota H; Hata K; Yagyu S; Seki T; Harada M; Kato Y; Mizuguchi J
Vaccine; 2014 Oct; 32(45):5918-24. PubMed ID: 25211769
[TBL] [Abstract][Full Text] [Related]
5. Immune effector cells induced by complete Freund's adjuvant exert an inhibitory effect on antigen-specific type 2 T helper responses.
Chuang YH; Chiang BL; Chou CC; Hsieh KH
Clin Exp Allergy; 1997 Mar; 27(3):315-24. PubMed ID: 9088658
[TBL] [Abstract][Full Text] [Related]
6. Aluminium hydroxide adjuvant initiates strong antigen-specific Th2 responses in the absence of IL-4- or IL-13-mediated signaling.
Brewer JM; Conacher M; Hunter CA; Mohrs M; Brombacher F; Alexander J
J Immunol; 1999 Dec; 163(12):6448-54. PubMed ID: 10586035
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-18 plays a role in both the alum-induced T helper 2 response and the T helper 1 response induced by alum-adsorbed interleukin-12.
Pollock KG; Conacher M; Wei XQ; Alexander J; Brewer JM
Immunology; 2003 Feb; 108(2):137-43. PubMed ID: 12562321
[TBL] [Abstract][Full Text] [Related]
8. Regulation of anaphylactic IgG1 antibody production by IL-4 and IL-10.
Silva AS; Cavalcante LT; Faquim-Mauro EL; Macedo MS
Int Arch Allergy Immunol; 2006; 141(1):70-8. PubMed ID: 16804329
[TBL] [Abstract][Full Text] [Related]
9. Vaccinations with T-helper type 1 directing adjuvants have different suppressive effects on the development of allergen-induced T-helper type 2 responses.
Trujillo-Vargas CM; Mayer KD; Bickert T; Palmetshofer A; Grunewald S; Ramirez-Pineda JR; Polte T; Hansen G; Wohlleben G; Erb KJ
Clin Exp Allergy; 2005 Aug; 35(8):1003-13. PubMed ID: 16120081
[TBL] [Abstract][Full Text] [Related]
10. A CpG-containing oligodeoxynucleotide as an efficient adjuvant counterbalancing the Th1/Th2 immune response in diphtheria-tetanus-pertussis vaccine.
Sugai T; Mori M; Nakazawa M; Ichino M; Naruto T; Kobayashi N; Kobayashi Y; Minami M; Yokota S
Vaccine; 2005 Nov; 23(46-47):5450-6. PubMed ID: 16006019
[TBL] [Abstract][Full Text] [Related]
11. Induction of IL-4-dependent, anaphylactic-type and IL-4-independent, non-anaphylactic-type IgG1 antibodies is modulated by adjuvants.
Faquim-Mauro EL; Macedo MS
Int Immunol; 2000 Dec; 12(12):1733-40. PubMed ID: 11099313
[TBL] [Abstract][Full Text] [Related]
12. Dietary ribonucleotides modulate type 1 and type 2 T-helper cell responses against ovalbumin in young BALB/cJ mice.
Jyonouchi H; Sun S; Winship T; Kuchan MJ
J Nutr; 2001 Apr; 131(4):1165-70. PubMed ID: 11285320
[TBL] [Abstract][Full Text] [Related]
13. Anti-interleukin-10 antibody restores burn-induced defects in T-cell function.
Kelly JL; Lyons A; Soberg CC; Mannick JA; Lederer JA
Surgery; 1997 Aug; 122(2):146-52. PubMed ID: 9288117
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant effect of zinc oxide on Th2 but not Th1 immune responses in mice.
Matsumura M; Nagata M; Nakamura K; Kawai M; Baba T; Yamaki K; Yoshino S
Immunopharmacol Immunotoxicol; 2010 Mar; 32(1):56-62. PubMed ID: 19811107
[TBL] [Abstract][Full Text] [Related]
15. Limiting dilution analysis of CD4 T-cell cytokine production in mice administered native versus polymerized ovalbumin: directed induction of T-helper type-1-like activation.
Gieni RS; Yang X; Kelso A; Hayglass KT
Immunology; 1996 Jan; 87(1):119-26. PubMed ID: 8666423
[TBL] [Abstract][Full Text] [Related]
16. Antigen dose defines T helper 1 and T helper 2 responses in the lungs of C57BL/6 and BALB/c mice independently of splenic responses.
Morokata T; Ishikawa J; Yamada T
Immunol Lett; 2000 May; 72(2):119-26. PubMed ID: 10841947
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulatory activity of novel adjuvant formulations based on Montanide ISA oil-based adjuvants and peptidoglycan monomer.
Habjanec L; Halassy B; Tomasić J
Int Immunopharmacol; 2008 May; 8(5):717-24. PubMed ID: 18387514
[TBL] [Abstract][Full Text] [Related]
18. The polyclonal and antigen-specific IgE and IgG subclass response of mice injected with ovalbumin in alum or complete Freund's adjuvant.
Beck L; Spiegelberg HL
Cell Immunol; 1989 Oct; 123(1):1-8. PubMed ID: 2776217
[TBL] [Abstract][Full Text] [Related]
19. In vivo IL-12 administration induces profound but transient commitment to T helper cell type 1-associated patterns of cytokine and antibody production.
Rempel JD; Wang M; HayGlass KT
J Immunol; 1997 Aug; 159(3):1490-6. PubMed ID: 9233648
[TBL] [Abstract][Full Text] [Related]
20. An ovalbumin-IL-12 fusion protein is more effective than ovalbumin plus free recombinant IL-12 in inducing a T helper cell type 1-dominated immune response and inhibiting antigen-specific IgE production.
Kim TS; DeKruyff RH; Rupper R; Maecker HT; Levy S; Umetsu DT
J Immunol; 1997 May; 158(9):4137-44. PubMed ID: 9126973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
